Search Results - "Ravishankar, Bellala"

Review of clinical applications and challenges with surface-guided radiation therapy by Bellala, Ravishankar, Kuppusamy, Anandakrishnan, Bellala, Venkat, Tyagi, Tulika, Manoharan, Surendhiran, Gangarapu, Gunasekhar, Bellala, Rishik

“…Aim: To evaluate the use of this new technique, surface-guided radiotherapy (SGRT), for patient setup and motion management in various cancers. Materials and…”
Get full text

Efficacy and Safety of Biosimilar Cetuximab Versus Innovator Cetuximab in Indian Patients With Head and Neck Cancer: A Multicenter, Randomized, Double-Blind, Phase III Trial by Prabhash, Kumar, Deshmukh, Chetan, Malhotra, Hemant, Sharma, Atul, Jain, Minish, Dhamne, Nilesh, Nagarakar, Rajnish, Ganesan, Prasantha, Mahobia, Vijay K., Das, Chandan K., Kumar, Rejnish, Shivanna, Prakash S., Avaronnan, Manu P., Chaithanya, Puligundla K., Chaudhary, Vaibhav, Singh, Kartar, Aagre, Suhas, Ravishankar, Bellala, Mehta, Dhruv, Shilpa, Kandipalli, Maniar, Vashishth, Chatterjee, Koushik, Majumdar, Saroj D., Dana, Rohitashwa, Noronha, Vanita, Menon, Nandini, Sharma, Akhilesh, Pawar, Roshan, Shahavi, Vinayaka, Yadav, Rajiv, Aiwale, Amol

“…Biosimilar vs Innovator Cetuximab in Indian Head & Neck Cancer Patients…”
Get full text

Abstract 5441: Down regulation of cysteine glutamate antiporter in ALDH1A1 expressing oral and breast cancer stem cells induced oxidative stress triggered ferroptosis by Bellala, Ravishankar

“…Background: Sulfasalazine, an xCT inhibitor, is being used as a repurposed antineoplastic drug to induce ferroptosis. Ferroptosis is a regulated necrotic cell…”
Get full text

Clinical and pathological correlation of p53expression in oral cancers by Bellala, Venkata Madhavi, Bellala, Ravishankar, Haranadh, Sriharsha, Kalagara, Akash, P, Venkateswar Rao, Sowjanya, Kasipeta

“…e18039 Background: p53 is a tumor suppressor protein, its overexpression is associated with survival and response treatment in squamous cell carcinoma of oral…”
Get full text

Bevacizumab biosimilar (MB02) and reference bevacizumab in patients with stage IIIB/IV non-squamous non-small cell lung cancer (NSCLC) (STELLA study): Multiple Imputation analysis by Trukhin, Dmytro, Poddubskaya, Elena, Zoran, Andric, Bondarenko, Igor, Shevnia, Serhii, Zaric, Bojan, Bellala, Ravishankar, Charoentum, Chaiyut, Perez, Luis, Bullo, Felicitas, Garcia, Fernanda

“…Abstract only e15003 Background: Stella Trial is a phase III, multinational, double-blind and randomized study to confirm clinical similarity between MB02 and…”
Get full text

Clinical and pathological correlation of P53 expression in oral cancers by Ravishankar, Bellala, Madhavi, Bellala Venkata, Kalagara, Akash, Bodepudi, Srija, Harnadh, Sriharsha, Bindu, P.Josephine, Pydi, Venkateswar Rao, Raj, Bellala Prithvi, Nitya, Gopireddy, Rishik, Bellala

“…In our study, we aimed to evaluate the overexpression of P53 in 155 oral squamous cell carcinomas and to correlate with various clinicopathological features…”
Get full text

Clinical and pathological correlation of P 53 expression in oral cancers by Ravishankar, Bellala, Madhavi, Bellala Venkata, Kalagara, Akash, Bodepudi, Srija, Harnadh, Sriharsha, Bindu, P Josephine, Pydi, Venkateswar Rao, Raj, Bellala Prithvi, Nitya, Gopireddy, Rishik, Bellala

“…In our study, we aimed to evaluate the overexpression of P in 155 oral squamous cell carcinomas and to correlate with various clinicopathological features like…”
Get full text